Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry of patients treated for blood clots

Official title: Standardized, Guidelines Directed But Patients Oriented Clinical Practice Prospectively Registered

Run by Mayo Clinic · NCT03504007 · Data updated 2026-11-12

This study collects information from patients with blood clots to see how well they respond to treatment and to ensure they get the right care quickly.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorMayo Clinic
Academic / other
Locations1 site (Rochester, Minnesota)
StatusRecruiting
StartedMarch 1, 2013
Main results expectedMarch 2033
Study endsMarch 2033
Registry record updatedApril 27, 2026
Trial IDNCT03504007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with acute VTE who begin anticoagulation treatment within 14 days of diagnosis.

Probably not a fit

Patients already on anticoagulation for other reasons or those enrolled in other anticoagulation trials may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on patients diagnosed with venous thromboembolism (VTE) at the Mayo Clinic's Thrombophilia Clinic. It employs a standardized approach to assess and treat patients with acute deep vein thrombosis and pulmonary embolism, ensuring timely anticoagulation therapy. The study monitors outcomes such as recurrence rates, bleeding events, and survival during the treatment period. Patients receive personalized care based on guidelines, with immediate access to necessary medications.

Why it matters

Potential benefit: If successful, this registry could improve treatment protocols and patient outcomes for those suffering from VTE.

How similar studies have gone: Other registries focusing on anticoagulation therapy for VTE have shown success in improving patient outcomes and treatment adherence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

• VTE seen at Thrombophilia Clinic and treatment with anti-coagulant is started within 14 days of VTE diagnosis date.

Exclusion Criteria:

* Patients already on anticoagulation for other reasons or enrolled into anticoagulation clinical trials.

Where it's running

  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.